【结 构 式】 |
【分子编号】14124 【品名】1,2,3,4-Tetrahydroisoquinoline 【CA登记号】91-21-4 |
【 分 子 式 】C9H11N 【 分 子 量 】133.19308 【元素组成】C 81.16% H 8.32% N 10.52% |
合成路线1
该中间体在本合成路线中的序号:(I)The acetylation of 1,2,3,4-tetrahydroisoquinoline (I) with acetic anhydride gives 2-acetyl-1,2,3,4-tetrahydroisoquinoline (II), which is sulfonated with chloro sulfonic acid in methylene chloride yielding 2-acetyl-7-chlorosulfonyl-1,2,3,4-tetrahydroisoquinoline (III). The reaction of (III) with 3-chloroaniline (IV) and triethylamine in refluxing acetone affords 2-acetyl-7-(3-chlorophenylamino sulfonyl)-1,2,3,4-tetrahydroisoquinoline (V), which is deacetylated by a treatment with HCl in refluxing butanol to 7-(3-chlorophenylaminosulfonyl)-1,2,3,4-tetrahydroisoquinoline (VI). Finally, this compound is condensed with bis(chlorosulfonyl)imide (VII) [prepared with chlorosulfonic acid (VIII) and chlorosulfonyl isocyanate (IX)] in acetonitrile containing triethylamine.
【1】 Ali Fadia E. (SmithKline Beecham Corp.); N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolino]disulfonylimides and antiallergic compositions and method of use. DD 158240; EP 0038177; US 4135935 . |
【2】 Serradell, M.N.; Chu, S.S.; Castaner, J.; SKF-88046. Drugs Fut 1985, 10, 1, 42. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14124 | 1,2,3,4-Tetrahydroisoquinoline | 91-21-4 | C9H11N | 详情 | 详情 |
(II) | 29003 | 1-[3,4-dihydro-2(1H)-isoquinolinyl]-1-ethanone | C11H13NO | 详情 | 详情 | |
(III) | 29004 | 2-acetyl-1,2,3,4-tetrahydro-7-isoquinolinesulfonyl chloride | C11H12ClNO3S | 详情 | 详情 | |
(IV) | 25239 | 3-chloroaniline; 3-chlorophenylamine | 108-42-9 | C6H6ClN | 详情 | 详情 |
(V) | 29005 | 2-acetyl-N-(3-chlorophenyl)-1,2,3,4-tetrahydro-7-isoquinolinesulfonamide | C17H17ClN2O3S | 详情 | 详情 | |
(VI) | 29006 | N-(3-chlorophenyl)-1,2,3,4-tetrahydro-7-isoquinolinesulfonamide | C15H15ClN2O2S | 详情 | 详情 | |
(VII) | 29007 | Bis(chlorosulfonyl)imide | HCl2NO4S2 | 详情 | 详情 | |
(VIII) | 29008 | Chlorosulfonic acid | 7790-94-5 | HClO3S | 详情 | 详情 |
(IX) | 14101 | Chlorosulfonyl isocyanate | 1189-71-5 | CClNO3S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(III)Protection of the amino group of 2-aminoethanol (I) with di-tert-butyldicarbonate, followed by reaction with phenylchlorocarbonate, gives 2-(tert-butoxycarbonylamino)ethylphenylcarbonate (II), which on reaction in refluxing 1,2,3,4-tetrahydroisoquinoline (III) yields 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 2-(tert-butoxycarbonylamino)ethyl ester (IV). Compound (IV) is deprotected with HCl in methanol to give 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 2-aminoethyl ester (V), which is coupled with 3-(N-tert-butoxycarbonyl-N-phenylamino)propanoic acid (VI) in the presence of dicyclohexylcarbodiimide to afford N-[2-(1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyloxy)ethyl]-3-(N'-tert-butoxycarbonyl-N'-phenylamino)propanamide (VII). Deprotection of (VII) with HCl in methanol gives N-[2-(1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyloxy)ethyl]-3-(phenylamino)propanamide (VIII), which is acylated with 5-bromonicotinoyl chloride hydrochloride (IX) in the presence of triethylamine to yield 3-bromo-5-[N-phenyl-N-[2-[2-(1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyloxy)ethylcarbamoyl]ethyl]carbamoyl]pyridine (X). Compound (X) is finally reacted with iodopropane and iodide anion exchanged by nitrate with IRA-410 (NO3-).
【1】 Tsushima, S.; Takatani, M.; Nishikawa, K. (Takeda Chemical Industries, Ltd.); Pyridinium nitrate, its production and use. EP 0382380; JP 1990275876; US 4981860 . |
【2】 Mealy, N.; Prous, J.; Castaner, J.; TCV-309. Drugs Fut 1993, 18, 8, 721. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10259 | Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol | 141-43-5 | C2H7NO | 详情 | 详情 |
(II) | 14123 | 2-[(tert-butoxycarbonyl)amino]ethyl phenyl carbonate | C14H19NO5 | 详情 | 详情 | |
(III) | 14124 | 1,2,3,4-Tetrahydroisoquinoline | 91-21-4 | C9H11N | 详情 | 详情 |
(IV) | 14125 | 2-[(tert-butoxycarbonyl)amino]ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate | C17H24N2O4 | 详情 | 详情 | |
(V) | 14126 | 2-aminoethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate | C12H16N2O2 | 详情 | 详情 | |
(VI) | 14127 | 3-[(tert-Butoxycarbonyl)anilino]propionic acid | C14H19NO4 | 详情 | 详情 | |
(VII) | 14128 | 2-([3-[(tert-butoxycarbonyl)anilino]propanoyl]amino)ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate | C26H33N3O5 | 详情 | 详情 | |
(VIII) | 14129 | 2-[(3-anilinopropanoyl)amino]ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate | C21H25N3O3 | 详情 | 详情 | |
(IX) | 14130 | 5-Bromonicotinoyl chloride | 39620-02-5 | C6H3BrClNO | 详情 | 详情 |
(X) | 14131 | 2-[(3-[[(5-bromo-3-pyridinyl)carbonyl]anilino]propanoyl)amino]ethyl 3,4-dihydro-2(1H)-isoquinolinecarboxylate | C27H27BrN4O4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(II)Regioselective substitution of the 2-chloro group of 2,4-dichloroquinoline (I) with 1,2,3,4-tetrahydroisoquinoline (II) in refluxing toluene provides the 2-(tetrahydroisoquinolinyl)quinoline (III). Then, displacement of the remaining 4-chloro group by heating with ethanolamine (IV) furnishes the title compound
【1】 Pinard, E.; Alanine, A.; Bourson, A.; Buttelman, B.; Heitz, M.-P.; Mutel, V.; Gill, R.; Trube, G.; Wyler, R.; 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorg Med. Chem. Lett 2002, 12, 18, 2615. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 61332 | 2,4-Dichloroquinoline | C9H5Cl2N | 详情 | 详情 | |
(II) | 14124 | 1,2,3,4-Tetrahydroisoquinoline | 91-21-4 | C9H11N | 详情 | 详情 |
(III) | 61333 | 4-chloro-2-[3,4-dihydro-2(1H)-isoquinolinyl]quinoline | C18H15ClN2 | 详情 | 详情 | |
(IV) | 10259 | Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol | 141-43-5 | C2H7NO | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(II)The title compound is prepared by condensation of 4-amino-2-bromopyridine (I) with an excess of tetrahydroisoquinoline (II) at 130 C
【1】 Büttelman, B.; Alanine, A.; Bourson, A.; Gill, R.; Heitz, M.-P.; Mutel, V.; Pinard, E.; Trube, G.; Wyler, R.; 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorg Med Chem Lett 2003, 13, 5, 829. |